List of Studies ( Metabolite:Cer 18:1;O2/18:3)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003645 | AN005984 | Targeting the c-MYC/ELOVL6 Pathway Alters Cell Membrane Mechanics and Enhances Chemotherapeutic Efficacy in Pancreatic Cancer | Cultured cells | Human | Cancer | Universidad Francisco de Vitoria - Hospital 12 de Octubre | LC-MS |
| ST002843 | AN004653 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002842 | AN004651 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Fenofibrate) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002411 | AN003930 | Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract (MS RP negative data) | Intestine | Human | University of California, Davis | LC-MS | |
| ST002334 | AN003810 | Phospholipase D3 impact on the endolysosomal lipidome | Cultured cells | Human | Alzheimers disease | VIB-KU Leuven | LC-MS |
| ST001687 | AN002754 | Non-transformed cells respond to fat by inducing glucose metabolism | Liver | Mouse | VIB-KU Leuven Center for Cancer Biology | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS |
